健择

健择是30年来美国FDA首次批准的用于治疗晚期胰腺癌的有效药物。

Gemzar is the first drug approved by the FDA in more than 30 years for the treatment of patients with advanced pancreatic carcinoma .

[目的]观察支气管动脉灌注顺铂（DDP80mg/m2）、健择（12g）治疗中、晚肺癌的疗效。

[ Objective ] To observe the effect of advanced lung cancer treated by bronchial arterial infusion with DDP ( 80mg / m 2 ) and Gemzar ( 1.2g ) .

前言：目的：研究健择和多西紫杉醇联合方案治疗晚期非小细胞肺癌（NSCLC）的疗效。

AIM : To study the efficiency and toxicities of docetaxel gemcitabine combination on advanced non small cell lung cancer ( NSCLC ) .

目的观察健择（GEM）加顺铂（DDP）联合治疗晚期非小细胞肺癌，临床疗效及毒副反应。

Objective To observe the clinical effects of using gemcitabine ( GEM ) combined with cisplatin ( DDP ) in treating advanced non-small cell lung cancer and its side effects .

目的：观察在CT引导下射频消融（RFA）结合健择+顺铂治疗周围型非小细胞肺癌（NSCLC）的短期疗效和安全性。

Objective : To investigate the short term efficacy and safety of radiofrequency ablation ( RFA ) and gemcitabine + cisplatin ( GP ) treating peripheral non small cell lung cancer ( NSCLC ) under CT guidance .

目的：观察高能聚焦超声（HIFU）与GF（G：健择，F：氟尿嘧啶）方案化疗联合治疗晚期胰腺癌近期疗效和毒副作用。

Objective : To observe the proximate efficacy and toxicity of thermotherapy of high intensive focus ultrasound ( HIFU ) in combination with chemotherapy ( Gemcitabine and Fluorouracil ) on treating advanced pancreatic cancer .

目的研究烟曲霉醇（TNP-470）联合健择（Gem）对人肺腺癌细胞（A549）和人脐静脉内皮细胞（ECV-304）血管内皮生长因子（VEGF）及其受体FLT-1、KDR表达的抑制作用。

Objective To investigate the effect of TNP-470 and Gemcitabine ( Gem ) on the expression of VEGF , FLT-1 , KDR in human pulmonary adenocarcinoma A549 cells and umbilical vein endothelium ECV-304 cells .

目的：观察参附注射液（SHF）对健择联合顺铂（GP）这一化疗方案治疗非小细胞肺癌过程中的减毒作用和对患者生活质量变化的影响。

Objective : To observe the therapeutic effect of Shenfu Injection ( SHF ) decreasing the toxicities and improving the quality of life in the patients with advanced Non-Small Cell Lung Cancer ( NSCLC ) with Gemcitabine plus Cisplatin ( GP ) .

联合用药最有效的是氟尿嘧啶+丝裂霉素+阿糖胞苷，91.6%（11/12）的标本对其敏感，其次是氟尿嘧啶+顺铂+阿霉素，健择+顺铂和5-FU氟尿嘧啶+长春新碱+卡氮芥。

5-fluorouracil + mitomycin + aytarabine was found to be the most effective combination in , for 91.6 % ( 11 / 12 ) specimens were sensitive to this regimen . 5-fluorouracil + cisplatin + adriamycin , gemcitabine + cisplatin and 5-fluorouracil + vincristine + carmustine were moderately active regi-mens .

采用ATP-TCA法对24例PEOC患者手术切除的新鲜癌组织进行体外药物敏感性测定，分别检测对泰素、顺铂、健择、阿霉素、拓扑替康5种化疗药物的敏感性。

ATP-TCA was used to detect the sensitive rate of 24 specimens of fresh ovarian cancer to five cytotoxic drugs as follows : paclitaxel ( TAX )、 gemcitabine ( GEM )、 doxorubicin ( ADM )、 topotecan ( TPT )、 cisplatin ( DDP ) .

肺癌、乳腺癌用健择加顺铂方案；

NSCLC and breast cancer were treated by gemcitabine plus cisplatin ;

动脉介入健择、顺铂治疗肺癌的临床研究

Application Study of Gemcitabine and Cisplatin in Interventional Therapy on Advanced NSCLC

健择加顺铂联合化疗治疗晚期膀胱癌38例

Combination Chemotherapy of Gemcitabine and Cisplatin for Advanced Bladder Cancer

健择在难治性非霍奇金淋巴瘤治疗中的应用研究

Clinical Applications of Gemcitabine in the Treatment of Refractory Non-Hodgkin 's Lymphoma

健择联合卡铂治疗卵巢癌疗效观察

Combined chemotherapy of gemcitabine and carboplatin in the treatment of ovarian cancer

放疗同步健择与顺铂化疗对大鼠脊髓损伤的实验研究

Rats spinal cord injury caused by gemcitabine and cisplatin combined with synchronous radiotherapy

射频消融结合健择顺铂治疗肺癌的短期疗效与安全性

Short-term Efficacy and Safety of Radiofrequency Ablation and Gemcitabine plus Cisplatin Treating Lung Cancer

胰腺癌细胞对5氟脲嘧啶和健择的获得性耐药机制的研究

The mechanism by which pancreatic cancer cells acquire drug resistance against 5-FU and gemcitabine

方法：38例中晚期胰腺癌患者接受动脉灌注健择治疗，其中28例曾行胆道支架置入术。

Methods : Gemeitabine was administered to 38 patients with advanced pancreatic carcinoma via interarterial catheter .

健择在晚期软组织肉瘤二线治疗中的作用

The Effect of Gemcitabine on Second - line Treatment for Patients with Advanced Soft Tissue Sarcomas

健择和晚期胰腺癌

Gemzar and advanced pancreatic carcinoma

结论健择联合腹腔灌注顺铂对原发性肝细胞癌有明显的治疗效果。

Conclusion The treatment of gemcitabine combined cisplatin peritoneal perfusion had curative effect on primary hepatocellular carcinoma .

结论健择联合顺铂是治疗晚期胰腺癌的1种安全有效的化疗方案。

Conclusion Gemcitabine plus cisplatin is an effective and safe chemotherapeutic regimen for the treatment of advanced pancreatic cancer .

健择与诺维本联合顺铂方案治疗晚期非小细胞肺癌的临床评价

The Clinical Evaluation of Advanced Non Small Cell Lung Cancer Treated with Gem , NVB and DDP Combination Chemotherapy

健择联合乐沙定治疗非小细胞肺癌病人毒副反应的观察及护理

Observation and nursing care of nonsmall-cell lung cancer patients with adverse reactions after accepted Gemzar combined with Eloxatin treatment

健择合并顺铂治疗晚期复治恶性肿瘤25例报告

The Effect of Combination Chemotherapy with Gemcitabine and Cisplatin in Advanced Relapse Malignant Tumor ── A Report of 25 Cases

血管抑素与顺铂及健择联用对人血管内皮细胞增殖和凋亡相关蛋白表达的影响

Effects of angiostatin , cisplatin and gemcitabine on proliferation of the vascular endothelial cells and its expression of apoptosis related protein

赫赛汀与健择以序贯方式联合应用对乳腺癌细胞抑制作用的研究

Effect of combined treatment of herceptin and gemcitabine in different sequences on tumoricidal activity against human breast cancer cells in vitro

目的探讨低剂量健择增敏放射治疗胰腺癌的疗效及毒副反应。

Objective To study the effects of the low-dose gemcitabine sensitizing radiotherapy to the Pancreatic cancer as well as its toxic side effects .

结论：康莱特注射液与健择对移植于裸鼠的人胰腺癌的抑制作用具有协同效应。

CONCLUSION : Kanglaite combined with Gemzar could inhibit the growth of the transplanted human pancreatic carcinoma in nude mice and has synergistic effect .